John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia; Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia.
John Hunter Hospital, Hunter New England Health, Newcastle, NSW, Australia; Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia.
Heart Lung Circ. 2023 Jun;32(6):658-665. doi: 10.1016/j.hlc.2023.03.007. Epub 2023 May 5.
Transcatheter mitral valve repair (TMVr) has emerged as a safe and effective alternative to conventional surgery in patients with primary and secondary mitral regurgitation, especially those at high surgical risk. This review summarises alternative indications for TMVr outside of the traditional criteria derived from the major randomised trials and focusses on less common mitral valve anatomies such as commissural prolapse and bileaflet prolapse, patients with mitral annuloplasty rings, as well as acutely unwell patients with papillary muscle rupture and/or cardiogenic shock. Specific technical challenges involved in treating such patient groups are summarised and described.
经导管二尖瓣修复术(TMVr)已成为原发性和继发性二尖瓣反流患者的一种安全有效的替代传统手术的方法,特别是对于高手术风险的患者。本综述总结了源于主要随机试验的传统标准之外,TMVr 的其他适应证,重点关注一些不太常见的二尖瓣解剖结构,如瓣叶交界处脱垂和双瓣叶脱垂、二尖瓣环成形术患者,以及伴有乳头肌破裂和/或心源性休克的急性失代偿患者。本文总结并描述了治疗这些患者群体时涉及的特定技术挑战。